These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3670653)

  • 1. [Use of defibrotide in dystrophic lesions of the lower limb in the varico-phlebitic syndrome].
    Cavalli A; Discalzo L; Dal Bo R; Corno F; Cimarelli S
    Minerva Chir; 1987 Jul; 42(13-14):1199-202. PubMed ID: 3670653
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of defibrotide in the treatment of acute superficial thrombophlebitis of the legs].
    Seccia M; Bortolotti P; Bellomini MG; Buccianti P; Chiarugi M; Cavina E
    Minerva Chir; 1989 May; 44(9):1379-84. PubMed ID: 2761740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of dichloroethanoate of di-isopropylammonium in the treatment of varicose and post-phlebitic ulcers].
    Fernando Farrera C; Salvador Tamayo T; Guillermo Miralles G
    Angeiologie; 1969; 21(3):127-31. PubMed ID: 5769317
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of chronic obliterative arteriopathy of the legs in the second Fontaine's stage. Personal experience with a buflomedil-pentoxifylline-defibrotide combination].
    Marci M; Albiani B; Ricci M; Russo F
    Clin Ter; 1995 Mar; 146(3):211-4. PubMed ID: 7789083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical observations on the use of F.I. 6321 on reparative processes of cutaneous lesions].
    Stoppani L; Trassini R
    Ann Ital Chir; 1969; 45(2):321-33. PubMed ID: 5399454
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of the efficacy of profibrinolytic treatment with defibrotide in the therapy of thrombophlebitis].
    Murgiano GA
    Clin Ter; 1988 Dec; 127(5):355-61. PubMed ID: 2976633
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of defibrotide in patients with chronic deep insufficiency. The PROVEDIS study.
    Coccheri S; Andreozzi GM; D'Addato M; Gensini GF;
    Int Angiol; 2004 Jun; 23(2):100-7. PubMed ID: 15507885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of deep venous thrombosis. A prospective study of defibrotide].
    Mensa G; Dominici P; Bouzari H; Colarelli G; Capusotti L; Dellepiane M
    Minerva Chir; 1988 Aug; 43(15-16):1275-8. PubMed ID: 3060758
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of deep venous thrombosis with defibrotide. Pilot study].
    Sammarco M; Garofalo M; Nazzari M
    Minerva Med; 1988 Jun; 79(6):495-7. PubMed ID: 2967927
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrinolytic effects of defibrotide in atherosclerotic patients.
    Patrassi GM; Sartori MT; Viero ML; Scapinello MP; Boeri G; Girolami A
    Semin Thromb Hemost; 1991; 17 Suppl 1():101-5. PubMed ID: 2068562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phlebo-lymphatic surgery in the treatment of the post-phlebitic syndrome].
    Battezzati M; Belardi P; Anfossi A
    Minerva Chir; 1975 Apr; 30(7):410. PubMed ID: 1128779
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical evaluation of di-isoproterenol dichloroethane in the treatment of post-phlebitic and varicose ulcers].
    Farrera F; Tamayo S; Miralles G
    Angiologia; 1969; 21(3):127-31. PubMed ID: 4389224
    [No Abstract]   [Full Text] [Related]  

  • 13. A pilot evaluation of the effects of defibrotide in patients affected by acute myocardial infarction.
    Carelli M; Citone C; Di Marcotullio G; Giampaolo P; Malinconico U; Polizzi C; Dell'Edera N; Gambelli GC; Cornelli U; Milazzotto F
    Semin Thromb Hemost; 1988; 14 Suppl():71-6. PubMed ID: 3194768
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical effectiveness of defibrotide in vaso-occlusive disorders and its mode of actions.
    Ulutin ON
    Semin Thromb Hemost; 1988; 14 Suppl():58-63. PubMed ID: 2848323
    [No Abstract]   [Full Text] [Related]  

  • 15. Defibrotide in sinusoidal obstruction syndrome: mounting evidence in pediatric patients (Commentary on Qureshi et al., page 831).
    Del Toro G
    Pediatr Blood Cancer; 2008 Apr; 50(4):735-6. PubMed ID: 18286500
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical trial of Ercevit P].
    Sourreil P; Beylot C
    Bord Med; 1971 May; 4(5):1681-92. PubMed ID: 5569955
    [No Abstract]   [Full Text] [Related]  

  • 17. [Action of N-acetyl-hydroxyproline in the treatment of cutaneous ulcerative lesions].
    Famulari C; Monaco M; Versaci A; Perri S; Terranova ML; Cuzzocrea D
    Ann Ital Chir; 1979; 51(5):527-36. PubMed ID: 555265
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of acute myocardial infarction with defibrotide.
    Mattioli G; Cappello C; Fusaro MT
    Semin Thromb Hemost; 1989 Oct; 15(4):470-3. PubMed ID: 2814517
    [No Abstract]   [Full Text] [Related]  

  • 19. [The action of defibrotide in the prevention of deep venous thrombosis].
    Bertoldo U; Alberghina A; Verna C; Pessione E; Olivero G
    Minerva Chir; 1988 Jan; 43(1-2):57-60. PubMed ID: 3362393
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparison of combined treatment for venous ulcers in postphlebitic syndrome and use of PGE-1--introductory remarks].
    Lazarkiewicz B; Winowski J; Zwoliński K; Kamiński R; Anil KA; Milan M; Skalski A; Ahmed K
    Wiad Lek; 1997; 50 Suppl 1 Pt 2():65-8. PubMed ID: 9424929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.